Review
doi: 10.1146/annurev.pharmtox.43.100901.135823. Epub 2002 Jan 10.Pharmacology and physiology of human adrenergic receptor polymorphisms
Affiliations
- PMID:12540746
- DOI: 10.1146/annurev.pharmtox.43.100901.135823
Item in Clipboard
Review
Pharmacology and physiology of human adrenergic receptor polymorphisms
Kersten M Small et al. Annu Rev Pharmacol Toxicol.2003.
Display options
Format
Display options
Format
Abstract
Adrenergic receptors are expressed on virtually every cell type in the body and are the receptors for epinephrine and norepinephrine within the sympathetic nervous system. They serve critical roles in maintaining homeostasis in normal physiologic settings as well as pathologic states. These receptors are also targets for therapeutically administered agonists and antagonists. Recent studies have shown that at least seven adrenergic receptor subtypes display variation in amino acid sequence in the human population due to common genetic polymorphisms. Variations in potential regulatory domains in noncoding sequence are also present. Here, we review the consequences of these polymorphisms in terms of signaling, human physiology and disease, and response to therapy.
Similar articles
- Polymorphisms of adrenergic receptors: variations on a theme.Liggett SB.Liggett SB.Assay Drug Dev Technol. 2003 Apr;1(2):317-26. doi: 10.1089/15406580360545134.Assay Drug Dev Technol. 2003.PMID:15090197Review.
- Adrenergic receptor polymorphisms and autonomic nervous system function in human obesity.Yasuda K, Matsunaga T, Adachi T, Aoki N, Tsujimoto G, Tsuda K.Yasuda K, et al.Trends Endocrinol Metab. 2006 Sep;17(7):269-75. doi: 10.1016/j.tem.2006.07.001. Epub 2006 Jul 21.Trends Endocrinol Metab. 2006.PMID:16860568Review.
- Pharmacogenetics of beta-1- and beta-2-adrenergic receptors.Liggett SB.Liggett SB.Pharmacology. 2000 Sep;61(3):167-73. doi: 10.1159/000028397.Pharmacology. 2000.PMID:10971202Review.
- Beta-adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics.Johnson JA, Terra SG.Johnson JA, et al.Pharm Res. 2002 Dec;19(12):1779-87. doi: 10.1023/a:1021477021102.Pharm Res. 2002.PMID:12523655Review.
- Pharmacogenetics of the human beta-adrenergic receptors.Taylor MR.Taylor MR.Pharmacogenomics J. 2007 Feb;7(1):29-37. doi: 10.1038/sj.tpj.6500393. Epub 2006 Apr 25.Pharmacogenomics J. 2007.PMID:16636683Review.
Cited by
- Association of polymorphisms in the beta-2 adrenergic receptor gene with fracture risk and bone mineral density.Veldhuis-Vlug AG, Oei L, Souverein PC, Tanck MW, Rivadeneira F, Zillikens MC, Kamphuisen PW, Maitland-van der Zee AH, de Groot MC, Hofman A, Uitterlinden AG, Fliers E, de Boer A, Bisschop PH.Veldhuis-Vlug AG, et al.Osteoporos Int. 2015 Jul;26(7):2019-27. doi: 10.1007/s00198-015-3087-0. Epub 2015 Apr 25.Osteoporos Int. 2015.PMID:25910744Free PMC article.
- Stereoselectivity in the Membrane Transport of Phenylethylamine Derivatives by Human Monoamine Transporters and Organic Cation Transporters 1, 2, and 3.Gebauer L, Rafehi M, Brockmöller J.Gebauer L, et al.Biomolecules. 2022 Oct 18;12(10):1507. doi: 10.3390/biom12101507.Biomolecules. 2022.PMID:36291716Free PMC article.
- Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins.Loomba R, Rao F, Zhang L, Khandrika S, Ziegler MG, Brenner DA, O'Connor DT.Loomba R, et al.Gastroenterology. 2010 Sep;139(3):836-45, 845.e1. doi: 10.1053/j.gastro.2010.06.009. Epub 2010 Jun 9.Gastroenterology. 2010.PMID:20537997Free PMC article.
- Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study.Nieminen T, Uusitalo H, Mäenpää J, Turjanmaa V, Rane A, Lundgren S, Ropo A, Rontu R, Lehtimäki T, Kähönen M.Nieminen T, et al.Eur J Clin Pharmacol. 2005 Dec;61(11):811-9. doi: 10.1007/s00228-005-0052-4. Epub 2005 Nov 17.Eur J Clin Pharmacol. 2005.PMID:16315032Clinical Trial.
- Beta blocker specificity: a building block toward personalized medicine.DeGeorge BR Jr, Koch WJ.DeGeorge BR Jr, et al.J Clin Invest. 2007 Jan;117(1):86-9. doi: 10.1172/JCI30476.J Clin Invest. 2007.PMID:17200711Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources